1. Introduction {#s0005}
===============

The term *schizophrenia spectrum disorder* has been used to describe a range of psychiatric conditions, including schizophrenia (SCZ), that share some genetic risk variants and clinical manifestations ([@bb0295]). Among these, schizotypal personality disorder (STP) is the most commonly included in studies of the spectrum. This condition is typically not associated with florid psychotic symptoms of schizophrenia (such as hallucinations and bizarre delusions), but rather cognitive or perceptual distortions and eccentricities in everyday behavior. Bipolar disorder (BP) is not traditionally included among the schizophrenia spectrum disorders, despite the fact that genetic and familial overlap is present with SCZ ([@bb0080]). Psychotic bipolar disorder (P-BP) has clinical similarities with SCZ and also has been reported to more closely overlap genetically with SCZ compared to nonpsychotic bipolar disorder (N-BP). Notwithstanding the relationship across these disorders, few studies have compared their brain structure ([@bb0310]). Such studies would provide information on the extent of similarities between disorders, and help clarify the phenotypic manifestations of specific genetic profiles.

Volumetric analyses of structural brain imaging data have been a mainstay of brain structure investigations in psychiatry. In recent years, developments in shape analysis methodology have led to structural measures that can supplement data derived from volumetric analysis. In studies of disease, investigation of the three-dimensional surfaces of brain subcortical structures have been shown to identify group abnormalities where the volumetric analysis did not, indicating that subtle surface abnormalities are more sensitive to shape than size ([@bb0310]). Since shape analysis enables the uncovering of localized deformations on the surface of a brain structure, it may more precisely identify impaired pathways within the brain. This is particularly important in the study of brain structures with explicit regional differentiation in function, such as the thalamus ([@bb0420]) or striatum ([@bb0500], [@bb0150], [@bb0265]). Previous shape analyses have been conducted in psychiatric patients, including those with SCZ,([@bb0310], [@bb0125], [@bb0440], [@bb0130], [@bb0225], [@bb0120], [@bb0315], [@bb0220], [@bb0375], [@bb0530], [@bb0455], [@bb0410], [@bb0305], [@bb0300], [@bb0045]) BP([@bb0380], [@bb0215], [@bb0510], [@bb0355], [@bb0280], [@bb0285]) or STP,([@bb0275], [@bb0270]) often with varying results. However, studies are often conducted using differing recruitment criteria, scanners, imaging protocols and analyses methodology, which can significantly influence results. Thus, investigating various diagnostic patient groups in a single study, with identical protocol, is therefore necessary to obtain valid comparisons. Our shape analysis represents the most extensive investigation of its kind to our knowledge, comparing multiple subcortical brain structures across several diagnostic groups. We used an automated shape analysis methodology involving Large Deformation Diffeomorphic Metric Mapping (LDDMM) that has been validated and previous applied in the evaluation of disease ([@bb0245], [@bb0085], [@bb0370]).

In the current study, we investigated the volumes and shapes of seven subcortical structures simultaneously (i.e. the hippocampus, amygdala, caudate, putamen, globus pallidus, nucleus accumbens, and thalamus). We compared findings in healthy controls to those of individuals with SCZ, psychotic (P-BP) and nonpsychotic (N-BP) bipolar disorder, and STP, obtained using the same MRI scanner, imaging protocol and analysis methodology. We hypothesize that overlapping structural abnormalities will exist across these groups, with SCZ most affected. Abnormalities are expected to be largely trend toward shrinkage, and be best captured by shape analysis. Due to a probable past history of typical antipsychotic drug use, we hypothesize that the basal ganglia in SCZ will be enlarged.

2. Materials and methods {#s0010}
========================

2.1. Participants {#s0015}
-----------------

The study was approved by the Institutional Review Board of Washington University. Participant groups included: 1) healthy controls (CON; n = 40); 2) bipolar disorder (BP; n = 73); 3) schizophrenia (SCZ; n = 52); and 4) schizotypal personality disorder (STP; n = 12). Participants\' ages ranged between 15 and 35 yrs. Participants were recruited through targeted advertisements in local psychiatric clinics, hospitals, and newspapers and through the Washington University volunteers for health recruitment system. All participants gave written informed consent for participation. SCZ and BP participants were all outpatients, and clinically stable for at least two weeks. They were diagnosed on the basis of a consensus between a research psychiatrist and a trained research assistant who used the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I). The Structured Clinical Interview for DSM-IV Axis II Disorders (SCID-II) was used to ascertain group diagnosis in STP participants. CON subjects were required to have no lifetime history of Axis I psychotic or mood disorders. Participants were excluded if they: (a) met DSM-IV criteria for substance dependence or severe/moderate abuse during the prior 6 months; (b) had a clinically unstable or severe general medical disorder; or (c) had a history of head injury with documented neurological sequelae or loss of consciousness. BP participants were subdivided into psychotic bipolar disorder (P-BP; N = 49) and nonpsychotic bipolar disorder (N-BP; N = 24) based on the presence or absence of a lifetime history of hallucinations and/or non-grandiose delusions using the SCID-I. Demographic data are shown in [Table 1](#t0005){ref-type="table"}.

2.2. Clinical assessment {#s0020}
------------------------

Psychopathology was assessed by trained Masters level research assistants using the Scale for the Assessment of Negative Symptoms (SANS) and the Scale for the Assessment of Positive Symptoms (SAPS) ([@bb0030]). Specific subscale scores were summed to derive measures of positive symptoms (i.e. hallucination and delusion subscales), disorganization (i.e. formal thought disorder, bizarre behavior and attention subscales), and negative symptoms (i.e. flat affect, alogia, anhedonia and amotivation subscales).

2.3. Image acquisition and surface mapping {#s0025}
------------------------------------------

Magnetic Resonance (MR) scans were obtained using a Siemens (Erlangen, Germany) 3T Tim TRIO Scanner at Washington University Medical School. T1-weighted images were acquired using a sagittal MPRAGE 3D sequence (TR = 2400 ms, TE = 3.16 ms, flip = 8°; voxel size = 1 × 1 × 1 mm).

Surfaces of the hippocampus, amygdala, basal ganglia (i.e. caudate, nucleus accumbens, putamen and globus pallidus), and thalamus were automatically generated using FS + LDDMM, as previously described ([@bb0245]). In brief, this method combines a probabilistic voxel-based classification method of FreeSurfer ([@bb0140]) and a deformable template-based method of large deformation diffeomorphic metric mapping (LDDMM) ([@bb0055]). The initial subcortical segmentations for the hippocampus, amygdala, basal ganglia and thalamus were obtained from FreeSurfer version 5.3.0, followed by image registration with LDDMM that produced smooth transformations for each region of interest (ROI). A previously-published template based on a healthy volunteer was used ([@bb0505]) to derive the segmentations and surfaces. Subcortical segmentations for the hippocampus and thalamus also included boundaries demarcating constituent subfields. Each ROI volume was calculated as the enclosed volume of the mapped surface. Intracranial volume, total gray matter volume and cortical white matter volume were obtained directly from the FreeSurfer pipeline output.

2.4. Statistical analyses {#s0030}
-------------------------

Statistical analyses (excluding shape) were done using SAS 9.4 (SAS Institute Inc., Cary, NC). Repeated measures ANCOVA (covaried for age and sex) were used to investigate volumetric group differences in subcortical brain regions, using hemisphere as the repeated measure. To investigate volumetric effects relative to brain size, intracranial volume was also included as a covariate in specific analyses. Relationships with volumes were explored using Pearson correlations, partialling out diagnosis, age and sex.

To compare structural shape across groups, surface displacement maps were first generated by computing the surface-normal component of the displacement of each surface vertex relative to the overall average for every participant. Then, pairwise group differences were examined using SurfStat,([@bb0105], [@bb0525]) comparing each clinical group with CON. For each group pair, a linear mixed-effects model was performed at each vertex, modeling the displacement and using group, age and sex as the independent predictors. This produced a coefficient estimate and pooled standard error for group, from which a t-statistic was calculated. Significance was corrected for multiple comparisons by applying random field theory (RFT),([@bb0005], [@bb0010]) and visualized as a color map on the overall average surface. RFT on surfaces was an extension of the body of work by Worsley and colleagues on detecting functional MRI activation in 3-dimensional volumetric data ([@bb0520], [@bb0465]). Multiple comparison correction methods such as Bonferroni or false discovery rate (FDR)([@bb0165]) are not appropriate because certain properties of the neuroimaging data are not considered by these methods ([@bb0365]). Namely, signals on adjacent vertices are correlated; signals may be spatially continuous (i.e., forming clusters) therefore the spatial extent of the signals must be considered in addition to peaks. RFT considers both peaks and spatial extent of the signal by modeling the noise as Gaussian random fields ([@bb0515], [@bb0100]). The topology is described by the expected Euler characteristic, which at high thresholds of the unadjusted p-value, becomes the expected number of clusters and approximates the family-wide error rate (FWER). On the surface, the expected Euler characteristic is calculated in terms of a search area, a roughness matrix and a given unadjusted p-value. The first two terms can be expressed together as counts of *resel* ([res]{.ul}olution [el]{.ul}ement), where resel is defined by the FWHM filter used to smooth the surface data. Then for a given unadjusted highly significant p-value at the vertex level, the Euler characteristic is the number of clusters, and the expected Euler characteristic approximates the adjusted p-value at the cluster level.

3. Results {#s0035}
==========

3.1. Intracranial, gray matter and white matter volumes {#s0040}
-------------------------------------------------------

Intracranial volumes showed a significant group effect (F = 3.6; p = 0.008). Least squared (controlling for age and sex) means of intracranial volumes were (in mm^3^): 1,518,123 for CON; 1,486,408 for SCZ; 1,525,578 for STP; 1,598,787 for P-BP; and 1,556,028 for N-BP. Post hoc analyses showed significant differences between SCZ and P-BP (p = 0.0004).

Total gray matter volumes showed a significant group effect (F = 3.9; p = 0.005). Least squared means of total gray matter volumes were (in mm^3^): 653,545 for CON; 622,722 for SCZ; 649,297 for STP; 667,948 for P-BP; and 660,335 for N-BP. Post hoc analyses showed significant differences between CON and SCZ (p = 0.01); SCZ and P-BP (p = 0.0002); and SCZ and N-BP (p = 0.01).

Total white matter volumes did not show a significant group effect (F = 1.8; p = 0.14).

3.2. Hippocampus volume and shape {#s0045}
---------------------------------

Hippocampal and other subcortical volumes are shown in [Table 2](#t0010){ref-type="table"}. After controlling for age and sex, there were no significant group effects. Including total intracranial volume as a covariate did not change non-significant group effects.

Hemispheric effects were significant (p \< 0.0001), but there was no group by hemisphere effect. Left hippocampi were smaller than right hippocampi. Shape analysis of the hippocampus resulted in significant group differences, as shown in [Fig. 1](#f0005){ref-type="fig"}A. Notable surface deformations in the hippocampus and other subcortical structures, across groups, are also displayed in [Table 3](#t0015){ref-type="table"}.

3.3. Amygdala volume and shape {#s0050}
------------------------------

There were no significant group differences in amygdala volumes. No significant group differences were present, with or without including total intracranial volume as a covariate. There were also no significant hemispheric effects for amygdala volume. [Fig. 1](#f0005){ref-type="fig"}B shows shape findings for the amygdala.

3.4. Caudate volume and shape {#s0055}
-----------------------------

There were no significant group effects for caudate volume; and there were no significant hemispheric effects. Shape findings involving the caudate are shown in [Fig. 1](#f0005){ref-type="fig"}C. Including total intracranial volume as a covariate resulted in a significant group effect for caudate volume (p = 0.001). Post hoc analyses showed the following significant group effects for caudate volume on the left: CON \> N-BP (p = 0.018); SCZ \> SPE (p = 0.012); SCZ \> P-BP (p = 0.0007); and SCZ \> N-BP (p = 0.0003). Significant volume effects on the right were: CON \> N-BP (p = 0.029); SCZ \> SPE (p = 0.04); SCZ \> P-BP (p = 0.003); and SCZ \> N-BP (p = 0.0005). By correcting shape findings for intracranial size, we explored the regions of the caudate contributing to the described volumetric group differences. As seen in [Fig. 2](#f0010){ref-type="fig"}A, the increase in caudate volume in SCZ is localized to the most anterior region of the head.

3.5. Nucleus accumbens volume and shape {#s0060}
---------------------------------------

There were no significant group effects for nucleus accumbens volume (with or without intracranial volume correction). There were no significant hemispheric effects for volume. [Fig. 1](#f0005){ref-type="fig"}D shows shape findings for the nucleus accumbens.

3.6. Putamen volume and shape {#s0065}
-----------------------------

There were no significant group effects for putamen volume. There were however significant hemispheric effects (p \< 0.0001), but no group by hemisphere effects. Putamina were smaller on the left than on the right. Shape findings for the putamen are shown in in [Fig. 1](#f0005){ref-type="fig"}E. Including total intracranial volume as a covariate resulted in a significant group effect for putamen volume (p = 0.006). Post hoc analyses showed the following significant group effects for volume on the left: CON \< SCZ (p = 0.01); SCZ \> P-BP (p = 0.004); and SCZ \> N-BP (p = 0.0003). Significant effects for putamen volume on the right were: CON \< SCZ (p = 0.03); SCZ \> P-BP (p = 0.02); and SCZ \> N-BP (p = 0.002). In SCZ, after correcting for intracranial volumes, surface expansion was observed in the posterior dorsal putamen, and laterally on the right ([Fig. 2](#f0010){ref-type="fig"}A). No surface expansion was seen in the other groups ([Fig. 2](#f0010){ref-type="fig"}B--D).

3.7. Globus pallidus volume and shape {#s0070}
-------------------------------------

There were no significant group effects or hemispheric effects for globus pallidus volume. Shape findings are shown in [Fig.1](#f0005){ref-type="fig"}F. Including total intracranial volume as a covariate resulted in a significant group effect for volume (p = 0.0007). Post hoc analyses showed the following significant group volume effects on the left: CON \< SCZ (p = 0.02); CON \> N-BP (p = 0.009); SCZ \> SPE (p = 0.02); SCZ \> P-BP (p = 0.004); SCZ \> N-BP (p \< 0.0001); and P-BP \> N-BP (p = 0.03). Significant volume effects on the right were: CON \< SCZ (p = 0.03); CON \> N-BP (p = 0.04); SCZ \> P-BP (p = 0.02); and SCZ \> N-BP (p = 0.0002). [Fig. 2](#f0010){ref-type="fig"}A shows surface deformation in SCZ after correcting for intracranial volumes. Regions of surface expansion were present dorsally along the ventrolateral edges.

3.8. Thalamus volume and shape {#s0075}
------------------------------

There were no significant group volume effects, and correcting for intracranial volumes did not change overall results. There were also no significant hemispheric effects for volume. Shape findings involving the thalamus are shown in [Fig. 1](#f0005){ref-type="fig"}G.

3.9. Clinical correlations {#s0080}
--------------------------

Correlation results are shown in [Table 4](#t0020){ref-type="table"}. Total gray matter volume inversely correlated with total SANS (r = − 0.25; p = 0.0009) and SAPS positive symptoms (r = − 0.2; p = 0.008), but not with SAPS disorganization symptoms. Cortical white matter volume showed a significant inverse relationship with the SANS (r = − 0.16; p = 0.03), but not with SAPS domains. Among the subcortical structures, significant clinical relationships were only found for the hippocampus, amygdala and thalamus. The left hippocampus only correlated with SAPS disorganization (r = − 0.19; p = 0.01) and SANS (r = − 0.21; p = 0.006). There were no significant correlations for the right hippocampus. Both left and right amygdala volumes were significantly related to SANS scores (left: r = − 0.17, p = 0.02; right: r = − 0.19, p = 0.01). Similarly, both left and right thalamus volumes were significantly related to SANS scores (left: r = − 0.16, p = 0.03; right: r = − 0.15, p = 0.049).

In those subcortical structures with group volume differences, vertex deformation was also investigated relative to clinical domain scores, excluding diagnosis, age and sex effects ([Fig. 3](#f0015){ref-type="fig"}). Hippocampal contraction with disorganization and negative symptoms was localized mainly to the lateral CA1 region. Additionally, negative symptoms were related to medial subiculum contraction. Positive symptoms, on the other hand were associated with anterior CA1 contraction ([Fig. 3](#f0015){ref-type="fig"}A). Reduced volumes of the amygdala with negative symptoms involved diffuse surface regions, most notably on the right posterior surface ([Fig. 3](#f0015){ref-type="fig"}B). Thalamus volume contraction with negative symptoms was localized to the lateral thalamic surface; while that with positive symptoms was mainly localized to the anterior and posterior extremes.

4. Discussion {#s0085}
=============

Shape analysis complements volumetric analysis, and can identify subtle regional abnormalities on brain structures helping to localize specific pathophysiologic pathways. Our study compared the volumes and shapes of multiple subcortical brain structures in healthy and psychiatric populations. We did not find absolute volumetric group differences for any of the subcortical structures studied, but some structures showed differences after controlling for brain size. Shape analysis on the other hand showed regional surface deformations in each diagnostic group. Contrary to our expectation, we only found little overlap in the pattern of deformation across groups.

4.1. Hippocampus {#s0090}
----------------

In our study, hippocampal shape analyses revealed regional group differences despite similar volumes across groups. In SCZ, the hippocampus was most deformed on the right side with shrinkage in the ventral subiculum. The subiculum receives input from CA1 and entorhinal cortical layer III pyramidal neurons and is the main output of the hippocampus ([@bb0435]). Given the widespread set of cortical and subcortical areas with which it interacts, it is able to influence activity in disparate brain regions ([@bb0435], [@bb0350]). Although the exact roles of the subiculum are unclear, it has been suggested that there is a segregation of function within the subiculum: the dorsal component mainly being involved in processing of spatial, movement and memory information; and the ventral component playing a major role in the inhibition of the HPA axis stress response ([@bb0350]). Smaller hippocampi is often seen in studies of SCZ patients,([@bb0415], [@bb0015]) as well as smaller subiculum volumes ([@bb0210]). Results regarding the location of hippocampal shrinkage however have varied across studies, having been reported in the head or anterior region([@bb0120], [@bb0315], [@bb0220], [@bb0375], [@bb0530]) and the body or tail ([@bb0280], [@bb0285]). Furthermore, CA1 regional deformation has been described in SCZ ([@bb0120], [@bb0435]). We found that in STP participants, the hippocampus was less deformed than in SCZ, without any notable overlapping regions. However, similar to SCZ, the STP group had hippocampal deformations in the subiculum, which thus may indicate a role of this region in schizophrenia spectrum disorder neurobiology. In the P-BP participants, hippocampal shrinkage involved regions outside of the subiculum and CA1; however N-BP participants had normal hippocampi suggesting that psychosis status in BP may be associated with hippocampal deformation. Smaller hippocampi are seen less commonly in BP than in SCZ ([@bb0360], [@bb0480]). Shrinkage of the head and medial border of the left hippocampus has been reported in BP, along with expansion on the right hippocampal tail medially ([@bb0385]). Our study results also showed a relationship between clinical symptoms and smaller hippocampal volumes on the left side. While our study did not show significant volumetric group effects, there was a trend level effect for left hippocampal volume in SCZ. This is consistent with some studies that have found a reduction in hippocampal size selectively on the left side ([@bb0230], [@bb0450]). Smaller left hippocampus has also been found to be a risk indicator for psychosis ([@bb0405]) and may indicate a preferential vulnerability of the left hippocampus to environmental stress ([@bb0450], [@bb0335], [@bb0430]).

4.2. Amygdala {#s0095}
-------------

Few studies have evaluated amygdala shape in psychiatric disorders. Surface deflation of the left amygdala has been reported in first episode mania and bilaterally in first episode SCZ ([@bb0380]). Others found bilateral shrinkage of the basolateral, basomedial and centromedial amygdala and the left lateral subregion in SCZ compared to P-BP([@bb0290]). Negative findings have also been reported in SCZ ([@bb0410]). In our study, we found that the amygdala in SCZ has several shrunken regions, principally those corresponding to lateral and centromedial subfields. Both BP subgroups showed more extensive shrinkage than SCZ. Regional deformation may be relevant to abnormal emotional processing, particularly in BP patients. Sensory inputs to the amygdala (e.g. from the hippocampus, primary auditory cortex, processed visual information from temporal cortex) terminate in the lateral nucleus. The structural organization and cellular composition of the lateral portions of the amygdala are cortex-like, and the majority of neurons are glutamatergic projection neurons. In contrast, the medial structures are striatum-like, and consist of GABAergic neurons ([@bb0260], [@bb0160]). Our findings therefore suggest structural abnormalities involving both excitatory and inhibitory neurons of the amygdala in SCZ and BP.

4.3. Thalamus {#s0100}
-------------

In the SCZ thalamus, we observed surface contraction in the pulvinar and ventral lateral nucleus. The pulvinar is a collection of nuclei with widespread connections to areas that include visual cortex, posterior parietal cortex, cingulate, premotor, prefrontal and the superior colliculi,([@bb0175]) and is involved in visual attention including linking visual stimuli with context-specific motor responses ([@bb0175], [@bb0040]). In addition to visual salience, the pulvinar also has been implicated in social cognition, including face processing ([@bb0060], [@bb0340], [@bb0395]). The ventral lateral nucleus targets efferents including the motor cortex, premotor cortex and supplementary motor cortex, facilitating the coordination and planning of movement. Previous shape studies in SCZ have found decreased sizes of various nuclei including the pulvinar, and the ventral lateral, anterior and mediodorsal nuclei ([@bb0125], [@bb0440], [@bb0130]). In the current study, the BP participants also showed posterior thalamic shrinkage. However, BP participants also had shrinkage in regions of the anterior and dorsal lateral nuclei. Connectionally and structurally, the lateral dorsal nuclei are reportedly similar to that of the anterior nuclei, and play a role in spatial memory and learning ([@bb0490]). The clinical relevance of the observed shape abnormalities is suggested by results of our correlational analyses, which showed that psychotic symptoms were localized to anterior and posterior thalamic nuclei.

4.4. Basal ganglia {#s0105}
------------------

Brain size corrected analyses resulted in significant group volume effects in the basal ganglia, driven primarily by enlargement in SCZ. Basal ganglia enlargement was localized to specific surface regions (across all nuclei), generally with some symmetry. The significance of the affected regions is unclear, and do not correlate with the distribution dopaminergic receptor subtypes ([@bb0390]). Considering the well documented medication effects on basal ganglia structures([@bb0300], [@bb0070], [@bb0320], [@bb0445], [@bb0485]), it is probable that basal ganglia enlargement in our study is a consequence of past use of typical antipsychotic drugs (such as haloperidol or fluphenazine), which are predominantly antagonists of the D~2~-subtype dopaminergic receptor. These receptors are highly abundant in the striatum, which have substantial dopaminergic afferents from the substantia nigra and the ventral tegmental area ([@bb0390], [@bb0195]). In animal studies, D~2~-receptor blockade has been shown to cause striatal enlargement in multiple studies ([@bb0095], [@bb0025], [@bb0495]). Most other investigators have also observed volume enlargement of basal ganglia nuclei in SCZ patients ([@bb0300], [@bb0070], [@bb0320], [@bb0445], [@bb0485]). A positive correlation between typical antipsychotic dose and striatal volume has been observed, supporting a trophic effect ([@bb0090], [@bb0135], [@bb0145], [@bb0185], [@bb0425], [@bb0460]). In contrast to volume increases with typical antipsychotics, normal ([@bb0180]) and decreased ([@bb0115], [@bb0240]) basal ganglia volumes are generally reported in neuroleptic-naïve patients or those on newer generation antipsychotic drugs. Also, an absence of basal ganglia enlargement in unaffected schizophrenia relatives is typical ([@bb0305], [@bb0445]) although some authors have found increased basal ganglia size in relatives ([@bb0345]). Several mechanisms underlying basal ganglia volume increase following D~2~-receptor blockade have been proposed. Disruption of the normal homeostatic mechanisms of target neurons in the basal ganglia appears to occur leading to a number of compensatory changes, manifesting as hypertrophy macroscopically ([@bb0025], [@bb0250]). Chronic haloperidol use has been associated with increased synaptic density in the striatum,([@bb0325], [@bb0330], [@bb0155]) mainly of the glutamatergic type([@bb0325], [@bb0235], [@bb0400], [@bb0475]) and possibly associated with increased synaptophysin expression([@bb0155]). Others have found increased neuronal size, particularly in axon terminals in the striatum,([@bb0235], [@bb0475], [@bb0065]) or an increase in the number of striatal neurons ([@bb0050], [@bb0255]). Complicating the understanding of antipsychotic trophic effects is that long-term treatment or high dosing can also induce neurotoxicity and loss of brain volume ([@bb0035], [@bb0075], [@bb0170], [@bb0020]). Therefore, dependent on drug concentration, treatment time and individual sensitivity, the neurotrophic or neurotoxic properties appear to determine basal ganglia volume increase or decrease respectively ([@bb0250]). By contrast to SCZ, both BP subgroups had multiple deflated regions, presumably since typical antipsychotics are infrequently used in these populations. This is particularly true for N-BP patients, who had the most extensive basal ganglia deflation. Basal ganglia surface deflation has been previously reported in BP, with variable findings: in the anterior and ventral striatum,([@bb0215]) dorsal caudate,([@bb0510]) left ventromedial caudate([@bb0355]) and right putamen ([@bb0280]). Others found no surface abnormality in BP, but a relationship of striatal deflation to illness severity ([@bb0285]).

4.5. Conclusions & limitations {#s0110}
------------------------------

In summary, our study found group differences in surface shapes of several subcortical brain structures, despite an absence of volumetric effects. Surface deformation patterns in individual diagnostic groups were largely unique; however related deformities were seen in the posterior thalamus in SCZ, P-BP and N-BP, as well as in the hippocampal subiculum in SCZ and STP. Basal ganglia surface enlargements in SCZ suggested typical antipsychotic drug effects. The results of our studies suggest distinct neurobiological abnormalities in each disorder, with minimal overlap across disorders. Findings however can be confounded by factors, which can limit the conclusion drawn from our study. Medications and recreational drugs could also influence brain structure (other than the basal ganglia), which are difficult to correct. For example, the typical antipsychotic drug, haloperidol has been reported to decrease cortical gray matter and whole brain volume,([@bb0495]) as well as subcortical structures such as the hippocampus ([@bb0315]). Lithium and antidepressant drugs have also been reported to increase cortical gray matter ([@bb0360], [@bb0495], [@bb0190], [@bb0110], [@bb0205]). However, studies showing similar regional deformations in nonpsychotic and unmedicated siblings of patients suggest that surface structural abnormalities can be fairly well estimated despite potential drug effects ([@bb0305], [@bb0200], [@bb0470]). The FS + LDDMM shape methodology, while robust, may also be less accurate in delineating smaller structures([@bb0245]). Thus, results may have underestimated shape abnormalities in the smaller nucleus accumbens or amygdala. Future studies involving more extensive behavioral measures, including cognition, would also be beneficial in further clarifying the clinical relationships of regional surface deformations. Developments in morphometric methods may allow more precise early identification of psychiatric disorders and risk states, and aid the monitoring of treatment effects.
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###### 

Shape analysis of individual subcortical structures. The figures depict displacement maps, generated from mean surfaces of the indicated diagnostic groups relative to healthy controls, for the: hippocampus (A), amygdala (B), caudate (C), nucleus accumbens (D), putamen (E), globus pallidus (F), and thalamus (G). Results were corrected for age and sex. Demarcation lines on hippocampal and thalamic surfaces separate designated subfields or nuclei, and are indicated on the first listed comparisons. Hippocampal subfields: CA1, subiculum (SUB), and the remaining regions which include CA2, CA3, CA4 and the dentate gyrus (REM). Thalamic nuclei: anterior nucleus (ANT), medial dorsal nucleus (MD), pulvinar (PUL), and the remaining nuclei (REM), which include the lateral dorsal, lateral posterior, ventral anterior, ventral lateral, ventral intermedial, and ventral posterior nuclei, as well as the medial and lateral geniculate bodies. Regions in green did not show significant group differences after RFT multiple comparison correction. T-values with cooler colors (t \< 0) indicate inward surface deformity, and warmer colors (t \> 0) indicate outward surface deformity. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
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![Shape analysis after brain size correction. The figures depict displacement maps for the basal ganglia (i.e. caudate, nucleus accumbens, putamen, and globus pallidus) and thalamus, presented together as they appear naturally. Maps were generated from mean surfaces of the indicated diagnostic groups relative to healthy controls. Results were corrected for age, sex and intracranial volume. Regions in green did not show significant group differences after RFT multiple comparison correction. T-values with cooler colors (t \< 0) indicate inward surface deformity, and warmer colors (t \> 0) indicate outward surface deformity. A = anterior; P = posterior; L = left; R = right.](gr2){#f0010}

![Shape relationships to clinical symptoms. The maps show regression coefficients for the hippocampus, amygdala, and thalamus against the positive, disorganized or negative symptoms. Cooler colors indicate inward surface deformity, and warmer colors indicate outward surface deformity.](gr3){#f0015}

###### 

Demographics table.

  Characteristics     Control      SCZ          Schizotypal   PBP          NPBP
  ------------------- ------------ ------------ ------------- ------------ ------------
  Age --- Mean (SD)   24.9 (5.0)   26.1 (4.1)   22.4 (3.5)    25.2 (3.6)   26.2 (3.7)
  Sex --- N (%)                                                            
  Female              20 (50.0)    14 (26.9)    5 (45.5)      29 (59.2)    16 (66.7)
  Male                20 (50.0)    38 (73.1)    6 (54.5)      20 (40.8)    8 (33.3)
  Race (%)                                                                 
  Asian               2 (5.0)      0            0             1 (2.0)      2 (8.3)
  Black               21 (52.5)    27 (51.9)    3 (27.3)      13 (26.5)    2 (8.3)
  Hispanic            0            0            0             3 (6.1)      0
  White               17 (42.5)    25 (48.1)    8 (72.7)      30 (61.2)    18 (75.0)
  Mixed/other         0            0            0             2 (4.1)      2 (8.3)
  Handedness                                                               
  Right               36 (90.0)    50 (96.2)    9 (81.8)      45 (91.8)    21 (87.5)
  Left                4 (10.0)     2 (3.8)      2 (18.2)      4 (8.2)      3 (12.5)

###### 

Subcortical volumes.

  Region              Control   SCZ    Schizotypal   PBP    NPBP   F     p
  ------------------- --------- ------ ------------- ------ ------ ----- ------------------------------------------
  Hippocampus                                                            
   Left                                                                  
   Absolute           2418      2330   2417          2512   2443   2.2   0.07
   Relative           2441      2396   2431          2431   2421   0.1   0.98
   Right                                                                 
   Absolute           2799      2742   2794          2903   2869         
   Relative           2827      2820   2811          2807   2843         
  Amygdala                                                               
   Left                                                                  
   Absolute           1350      1315   1326          1386   1340   1.7   0.16
   Relative           1364      1354   1334          1338   1327   0.4   0.81
   Right                                                                 
   Absolute           1392      1352   1376          1439   1391         
   Relative           1405      1390   1385          1392   1377         
  Caudate                                                                
   Left                                                                  
   Absolute           3549      3581   3399          3595   3432   1.0   0.43
   Relative           3588      3690   3422          3460   3396   4.6   0.001[\*](#tf0025){ref-type="table-fn"}
   Right                                                                 
   Absolute           3516      3555   3416          3584   3409         
   Relative           3553      3660   3439          3454   3373         
  Nucleus accumbens                                                      
   Left                                                                  
   Absolute           376       379    388           383    373    0.4   0.84
   Relative           380       388    390           371    370    1.2   0.31
   Right                                                                 
   Absolute           370       366    373           378    369          
   Relative           373       375    375           366    366          
  Putamen                                                                
   Left                                                                  
   Absolute           4767      4899   4868          4927   4692   1.2   0.33
   Relative           4811      5022   4894          4775   4651   3.6   0.008[\*](#tf0025){ref-type="table-fn"}
   Right                                                                 
   Absolute           5074      5192   5137          5258   5020         
   Relative           5119      5320   5165          5100   4977         
  Globus pallidus                                                        
   Left                                                                  
   Absolute           1648      1683   1615          1698   1589   1.9   0.11
   Relative           1663      1726   1624          1646   1575   4.9   0.0009[\*](#tf0025){ref-type="table-fn"}
   Right                                                                 
   Absolute           1652      1687   1631          1711   1608         
   Relative           1666      1728   1640          1661   1594         
  Thalamus                                                               
   Left                                                                  
   Absolute           7681      7495   7617          7751   7599   0.9   0.49
   Relative           7749      7689   7658          7512   7533   1.9   0.12
   Right                                                                 
   Absolute           7353      7225   7289          7438   7237         
   Relative           7412      7392   7325          7232   7181         

Reported volumes are in mm^3^.

All volumes and results were controlled for age and sex.

Results were derived from repeated measures ANOVA using hemisphere as a repeated measure.

p \< 0.01.

###### 

Notable subcortical shape findings.

  Surface Deformation            SCZ   STP   PBP   NPBP                     
  ------------------------------ ----- ----- ----- ------ ----- ----- ----- -----
                                 L     R     L     R      L     R     L     R
  **Hippocampus**                                                           
  Subiculum contraction          ~−~   ++    ~−~   \+     ~−~   ~−~   ~−~   ~−~
  CA2--4 + dentate contraction   ~−~   ~−~   ~−~   ~−~    ++    ++    ~−~   ~−~
  CA1 contraction                \+    ~−~   ~−~   ~−~    ~−~   ~−~   ~−~   ~−~
  CA1 expansion                  ~−~   ~−~   ~−~   \+     ++    ++    ~−~   ~−~
  **Amygdala**                                                              
  Posteriolateral contraction    ~−~   \+    ~−~   ~−~    ~−~   ~−~   ~−~   ~−~
  Posteriomedial contraction     ~−~   ~−~   ~−~   ~−~    ~−~   ~−~   \+    ++
  **Caudate**                                                               
  Ventral contraction            \+    ~−~   \+    ~−~    \+    \+    ~−~   ~−~
  Dorsal contraction             ~−~   ~−~   ~−~   ~−~    ~−~   ~−~   ++    ++
  Nucleus Accumbens                                                         
  Ventral contraction            ~−~   ~−~   ~−~   ~−~    \+    \+    ~−~   \+
  Dorsolateral expansion         ~−~   ~−~   ~−~   ~−~    \+    ~−~   ~−~   ~−~
  **Putamen**                                                               
  Posteromedial contraction      ~−~   ~−~   ~−~   ~−~    ~−~   ~−~   \+    \+
  Posterolateral expansion       ~−~   ~−~   ~−~   ~−~    ~−~   ~−~   \+    ~−~
  Mediolateral expansion         ~−~   ~−~   ~−~   ~−~    \+    \+    ~−~   ~−~
  Medial expansion               ~−~   ~−~   ~−~   ~−~    ~−~   ~−~   \+    \+
  Posterosuperior expansion      ~−~   ~−~   ~−~   ~−~    \+    \+    ~−~   ~−~
  **Globus pallidus**                                                       
  Anterosuperior contraction     ~−~   ~−~   ~−~   ~−~    ~−~   ~−~   ~−~   \+
  Inferior contraction           ~−~   ~−~   ~−~   ~−~    ~−~   ~−~   \+    \+
  Superiomedial expansion        \+    \+    ~−~   ~−~    ++    ++    ~−~   ~−~
  Lateral expansion              \+    ~−~   ~−~   ~−~    \+    \+    ~−~   ~−~
  **Thalamus**                                                              
  Anterior contraction           \+    ~−~   ~−~   ~−~    ~−~   ~−~   ++    ++
  Pulvinar contraction           \+    ~−~   ~−~   ~−~    ~−~   \+    ++    ++
  Superior contraction           \+    ~−~   ~−~   ~−~    ~−~   ~−~   ++    ++

Surface deformation estimates are derived from comparisons of mean groups to mean control subjects, and controlled for age and sex.

+: mild or moderate surface deformation.

++: large surface deformation.

###### 

Clinical correlations.

  Region                  Positive symptoms[a](#tf0010){ref-type="table-fn"}   Disorg. symptoms[b](#tf0015){ref-type="table-fn"}   Negative symptoms[c](#tf0020){ref-type="table-fn"}   p[a](#tf0010){ref-type="table-fn"}       p[b](#tf0015){ref-type="table-fn"}   p[c](#tf0020){ref-type="table-fn"}
  ----------------------- ---------------------------------------------------- --------------------------------------------------- ---------------------------------------------------- ---------------------------------------- ------------------------------------ -------------------------------------------
  Total gray matter       − 0.20                                               − 0.13                                              − 0.25                                               0.008[⁎](#tf0005){ref-type="table-fn"}   0.08                                 − 0.0009[⁎](#tf0005){ref-type="table-fn"}
  Cortical white matter   − 0.09                                               − 0.05                                              − 0.16                                               0.24                                     0.37                                 0.03[⁎](#tf0005){ref-type="table-fn"}
  Hippocampus                                                                                                                                                                                                                                                         
   Left                   − 0.14                                               − 0.19                                              − 0.21                                               0.06                                     0.01                                 0.006
   Right                  − 0.10                                               − 0.12                                              0.14                                                 0.17                                     0.12                                 0.06
  Amygdala                                                                                                                                                                                                                                                            
   Left                   − 0.08                                               − 0.13                                              − 0.17                                               0.28                                     0.09                                 0.02[⁎](#tf0005){ref-type="table-fn"}
   Right                  − 0.09                                               − 0.13                                              − 0.19                                               0.21                                     0.08                                 0.01[⁎](#tf0005){ref-type="table-fn"}
  Caudate                                                                                                                                                                                                                                                             
   Left                   − 0.05                                               − 0.11                                              − 0.09                                               0.49                                     0.15                                 0.24
  Right                   − 0.07                                               − 0.13                                              − 0.08                                               0.39                                     0.09                                 0.28
  Nucleus accumbens                                                                                                                                                                                                                                                   
   Left                   − 0.13                                               − 0.02                                              − 0.06                                               0.09                                     0.75                                 0.42
   Right                  − 0.14                                               − 0.02                                              − 0.09                                               0.07                                     0.77                                 0.26
  Putamen                                                                                                                                                                                                                                                             
   Left                   − 0.06                                               − 0.06                                              − 0.02                                               0.45                                     0.43                                 0.81
   Right                  − 0.08                                               − 0.06                                              − 0.03                                               0.32                                     0.33                                 0.67
  Globus pallidus                                                                                                                                                                                                                                                     
   Left                   0.00                                                 − 0.02                                              − 0.05                                               0.99                                     0.83                                 0.51
   Right                  − 0.03                                               − 0.01                                              − 0.04                                               0.67                                     0.82                                 0.63
  Thalamus                                                                                                                                                                                                                                                            
   Left                   − 0.15                                               − 0.07                                              − 0.16                                               0.04[⁎](#tf0005){ref-type="table-fn"}    0.36                                 0.03[⁎](#tf0005){ref-type="table-fn"}
   Right                  − 0.14                                               − 0.05                                              − 0.15                                               0.07                                     0.55                                 0.05[⁎](#tf0005){ref-type="table-fn"}

Relationships were analyzed using Pearson correlations partially controlled for diagnosis, age and sex.

relates to positive symptoms (derived from SAPS) Pearson\'s r or p values.

relates to disorganized symptoms (derived from SAPS) Pearson\'s r or p values.

relates to negative symptoms (derived from SANS) Pearson\'s r or p values.

p \< 0.05.
